Author

Agata Skrzat‐Klapaczyńska

Observed names: A Skrzat-Klapaczyńska, A Skrzat‐Klapaczyńska, A. Skrzat-Klapaczyńska, Agata Skrzat-Klapaczynska, Agata Skrzat-Klapaczyńska, Agata Skrzat-Klapaczyńska, Agata Skrzat-Klapczyńska, Agata Skrzat-Wojdacz, Skrzat-Klapaczyńska, Agata

Observed institutions: Vilnius University, University of Banja Luka, Charles University, Medical University of Warsaw, Fakultní nemocnice Bulovka, University of Medicine and Pharmacy of Craiova, Wojewódzki Szpital Specjalistyczny we Wrocławiu, Wojewódzki Szpital Obserwacyjno-Zakaźny im. Tadeusza Browicza w Bydgoszczy, University clinical center of Republika Srpska, Vilnius University Hospital Santariskiu Klinikos, Belarusian State Medical University

ORCID: 0000-0002-6367-5633

Observed ORCID: 0000-0002-6367-5633

OpenAlex ID: A5082109607

HIV care in times of the COVID-19 crisis — Where are we now in Central and Eastern Europe?

2020 · J.D. Kowalska, A. Skrzat-Klapaczyńska, et al. · International Journal of Infectious Diseases · 102

Unified European support framework to sustain the HIV cascade of care for people living with HIV including in displaced populations of war-struck Ukraine

2022 · Marta Vasylyev, Agata Skrzat-Klapaczyńska, et al. · The Lancet HIV · 68

The Association of Baseline Plasma SARS-CoV-2 Nucleocapsid Antigen Level and Outcomes in Patients Hospitalized With COVID-19

2022 · ACTIV-3/TICO Study Group, Angela J. Rogers, et al. · Annals of Internal Medicine · 60

National medical specialty guidelines of HIV indicator conditions in Europe lack adequate HIV testing recommendations: a systematic guideline review

2022 · Carlijn C.E. Jordans, Marta Vasylyev, et al. · Eurosurveillance · 30

Factors associated with urinary tract infections among HIV-1 infected patients

2018 · Agata Skrzat-Klapaczyńska, Bartłomiej Matłosz, et al. · PLoS ONE · 30

PrEP Scale-Up and PEP in Central and Eastern Europe: Changes in Time and the Challenges We Face with No Expected HIV Vaccine in the near Future

2023 · Deniz Gokengin, Dominik Bursa, et al. · Vaccines · 26

The Beneficial Effect of the COVID-19 Vaccine Booster Dose among Healthcare Workers in an Infectious Diseases Center

2022 · Agata Skrzat-Klapaczyńska, Carlo Bieńkowski, et al. · Vaccines · 26

Severe Breakthrough COVID-19 Cases during Six Months of Delta Variant (B.1.617.2) Domination in Poland

2022 · Piotr Rzymski, Monika Pazgan-Simon, et al. · Vaccines · 23

National strategies for vaccination against COVID‐19 in people living with HIV in Central and Eastern European region

2021 · David Jilich, Agata Skrzat‐Klapaczyńska, et al. · HIV Medicine · 21

The characteristics of HIV-positive patients with mild/asymptomatic and moderate/severe course of COVID-19 disease—A report from Central and Eastern Europe

2020 · Justyna D. Kowalska, Kerstin Kase, et al. · International Journal of Infectious Diseases · 20

Advanced age and increased CRP concentration are independent risk factors associated with Clostridioides difficile infection mortality

2020 · Agnieszka Bednarska, Dominik Bursa, et al. · Scientific Reports · 17

Viral and Host Factors Are Associated With Mortality in Hospitalized Patients With COVID-19

2024 · Neil R Aggarwal, Jacquie Nordwall, et al. · Clinical Infectious Diseases · 15

Systematic Review: Strategies for Improving HIV Testing and Detection Rates in European Hospitals

2024 · Klaske J. Vliegenthart-Jongbloed, Marta Vasylyev, et al. · Microorganisms · 15

Mpox across countries from Central and Eastern Europe - 2022 outbreak

2024 · Irina Ianache, Agata Skrzat-Klapaczynska, et al. · Travel Medicine and Infectious Disease · 13

Where are we with pre‐exposure prophylaxis use in Central and Eastern Europe? Data from the Euroguidelines in Central and Eastern Europe (ECEE) Network Group

2020 · T Balayan, J Begovac, et al. · HIV Medicine · 12

The Clinical Effectiveness and Safety of Vaccinations against COVID-19 in HIV-Positive Patients: Data from Observational Study in Poland

2023 · Carlo Bieńkowski, Agata Skrzat-Klapaczyńska, et al. · Vaccines · 11

Late diagnosis of HIV infection in Warsaw: Estimating the scale of the problem and demographic trends

2022 · Joanna Puła, Justyna Kowalska, et al. · HIV Medicine · 11

HIV treatment strategies across Central, Eastern and Southeastern Europe: New times, old problems

2022 · Antonios Papadopoulos, Konstantinos Thomas, et al. · HIV Medicine · 10

Immunological and Clinical Responses to Vaccinations among Adults Living with HIV

2024 · Carlo Bieńkowski, Zuzanna Żak, et al. · Life · 9

Differences and similarities in clinical manifestations of Listeria monocytogenes and Mycobacterium tuberculous meningitis

2020 · M Paciorek, C Bieńkowski, et al. · Przeglad Epidemiologiczny · 8

Vaccination against HBV and HAV as Mode of Hepatitis Prevention among People Living with HIV—Data from ECEE Network Group

2023 · Kerstin Aimla, Justyna Dominika Kowalska, et al. · Vaccines · 7

Early trajectories of virological and immunological biomarkers and clinical outcomes in patients admitted to hospital for COVID-19: an international, prospective cohort study

2024 · Tomas O Jensen, Thomas A Murray, et al. · The Lancet Microbe · 6

Chronic Kidney Disease and Nephrology Care in People Living with HIV in Central/Eastern Europe and Neighbouring Countries—Cross-Sectional Analysis from the ECEE Network

2022 · Bartłomiej Matłosz, Agata Skrzat-Klapaczyńska, et al. · International Journal of Environmental Research and Public Health · 6

The Management of HIV Care Services in Central and Eastern Europe: Data from the Euroguidelines in Central and Eastern Europe Network Group

2022 · Agata Skrzat-Klapaczyńska, Justyna D. Kowalska, et al. · International Journal of Environmental Research and Public Health · 6

The Presence of Either Typical or Atypical Radiological Changes Predicts Poor COVID-19 Outcomes in HIV-Positive Patients from a Multinational Observational Study: Data from Euroguidelines in Central and Eastern Europe Network Group

2022 · Justyna D. Kowalska, Carlo Bieńkowski, et al. · Viruses · 6

Works count: 63

Citation count: 626

H-index: 13

I10-index: 18